THE WOODLANDS, Texas and REGENSBURG, Germany, July 25, 2023 /PRNewswire/ -- The US Food and Drug Administration has cleared a Numares Health test, the AXINON ® LDL-p Test System, as a new tool ...
本研究通过UK Biobank队列41,099例数据,首次系统比较了载脂蛋白B(ApoB)与低密度脂蛋白颗粒数(LDL-P)在心血管风险预测中的差异。结果显示,当两者出现2%以上差异时,ApoB升高组的心血管事件风险显著增加(HR 1.1-2.5),而LDL-P升高未显示预测价值,证实ApoB是更优的动脉 ...
THE WOODLANDS, Texas and REGENSBURG, Germany, July 25, 2023 /PRNewswire/ -- The US Food and Drug Administration has cleared a Numares Health test, the AXINON ® LDL-p Test System, as a new tool ...
The FDA clearance also includes the company's core technology platform, the proprietary AXINON ® System, that incorporates diagnostic testing algorithms into nuclear magnetic resonance (NMR) ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果